4
Changes in Ownership
HCW Biologics Inc. Filed Acc 0001209191-23-033173
Chief Financial Officer bought 40,000 shares at an average $1.64 ($65,544)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Byam Rebecca Chief Financial Officer | 2023-05-25 | Purchase | +20,000 | $1.62 | $32,348 | 440,188 | D |
| Byam Rebecca Chief Financial Officer | 2023-05-26 | Purchase | +20,000 | $1.66 | $33,196 | 460,188 | D |
| Open-market purchases · 40,000 sh · avg $1.64 · $65,544 | |||||||
Loading xslF345X04/doc4.xml…